In this regard, alone or combined expression level of PD1 on CD4+ T-cells as well as the expression level of CD38 on CD8+ T-cells could be potential biomarkers in the prediction of disease severity and outcome in patients with COVID-19 [46, 77]. The gene discussed is CD4; the disease is COVID-19.